☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Sirius Therapeutics
Sirius Therapeutics Commences P-I Study of SRSD107 for Treating Thromboembolic Disorders
February 2, 2024
Load more...
Back to Home
Modal title
×
Modal body text goes here.